Like many other aspects of clinical research, the study of metabolic changes after operation would appear to pass through phases of interest. Present work being carried out in a number of departments concerned with the =tabolic response to surgery is directed towards a better understanding of the changes in carbohydrate metabolism after operation.
This interest has arisen from a number of developments during the past decade. In recent years there has been a remarkable increase in the use of carbohydrate solutions in parenteral nutrient regimes, especially outside Europe where intravenous fat solutions have not been available. Energy has therefore been provided from carbohydrate, mainly as hyperosmolar glucose solutions, administering quantities far in excess of the normal intake. The patients who have received this are often hypercatabolic and are known to have some limitation of their ability to assimilate glucose which has been associated with problems such as hypophosphatnmia. Furthermore, administering large glucose intakes with high doses of insulin to patients in hypercatabolic states has improved the rate of glucose uptake by the tissues and has also improved or reversed a number of the metabolic features we have come to accept as necessary or inevitable components of the metabolic response to injury (Allison et al. 1968 ). One implication of this work is that the intolerance to glucose may play a key role in the altered nutritional states of the injured patient. It has also been suggested by Kinney et al. (1970) that a function of part of the excess protein catabolized after injury may be to supply carbohydrate intermediates which are no longer available. A better understanding of the meaning and significance of these changes would therefore improve the nutritional management of the severely injured.
The knowledge that a change occurs in the ability of the patient to handle glucose after injury or infection is not new. In 1877 Claude Bernard showed that shock was associated with hyperglycwmia. Much later, Rosenthal (1914) used the response to pyrexia induced by diphtheria toxin to demonstrate that the liver became less capable of retaining glycogen and that severe hyperglycxemia was present when glucose was given. More detailed investigations in the 1950s by Hayes & Brandt (1952) , Drucker et al. (1953) and Howard (1955) demonstrated a state of glucose intolerance and insulin resistance in the period immediately after surgery. Recently it has been suggested that one of the factors which may be responsible is a suppression of insulin secretion during the postoperative period (Wright et al. 1974 ).
Glucose Tolerance and Insulin Secretion After Operation
This Unit has been studying the relationship between glucose and insulin before and after operation to define the capacity of the pancreas to secrete insulin when the effect of trauma is maximal and to what extent postoperative management affects this. Because the conventional glucose tolerance test uses a small bolus of glucose, it induces only a small and short-lived insulin response. We have used an infusion tolerance test to provide a period of sustained hyperglycemia and elicit a prolonged insulin response, which is therefore more representative of the clinical response of the pancreas. The dosage of glucose is 500 mg/kg for 3 minutes followed by 20 mg/kg for the next 45-60 minutes, which maintains the plasma glucose levels near 400 mg/100 ml during the infusion period. Two peaks of insulin secretion are elicited: 50-100 ,tu/ml within 15 minutes, and 80-140 ,uu/ml at 45-60 minutes. The first peak represents release of stored insulin and the second a response to infused glucose.
On the day after operation for vagotomy and pyloroplasty, the same glucose stimulus produces an elevation of glucose which on average is 50 mg/100 ml greater than preoperative levels. The insulin response is potentiated, the first peak being 160 ,tu/ml and the second peak 360 ,tu/ml. By the fifth postoperative day these have returned almost to preoperative values. Using the second peak of insulin as an index of pancreatic activity, trauma induces a change in the pancreatic response which is proportionately many times greater than the increase in glucose, indicating a disturbance in this relationship. With elective abdominal surgery of moderate severity the change in carbohydrate metabolism, although readily detectable, is therefore of very short duration.
However, it is possible that therapy can influence this response either by improving the nutritional status of the patient or by its physiological effects on the relationship between plasma glucose and insulin. We have used the glucose infusion tolerance test to demonstrate these effects in three groups of 6 patients having vagotomy and pyloroplasty, who have had different intravenous intakes for four days in the postoperative period. All patients were given the same intakes of fluid and electrolytes. One group was given glucose and another sorbitol to provide 2400 kcal/day. The control group received no nutrients. All tests were performed in the resting state on the day before operation, the day after operation, before therapy was started, and on the fourth day after operation, when therapy was completed. No significant difference could be detected in the plasma glucose levels between the groups on each of the test days. The most significant differences were found in the second peak of insulin secretion on the fourth postoperative day. Because all patients were managed identically on the day before and the day after operation, there was no difference between the second peaks of insulin secretion of the three groups. The mean level of the second insulin peak was 80 (± 16) ,tu/ml on the day before operation and 211 (±44) pu/ml on the day after operation. After therapy on the fourth day the glucose group had an insulin peak of 325 (±80) ,uu/ml, the sorbitol group 164 (±21) ,uu/ml and the control group 86 (±47) ,uu/ml, both the glucose and sorbitol levels being significantly different from the control (P<0.001). The capacity of the pancreas to secrete insulin in response to a standard glucose load has therefore been changed by management in the postoperative period.
Discussion
The study of this aspect of postoperative metabolism has two objects in mind, being directed towards a clearer understanding of the mechanisms involved and also to determine the relevance of these changes to postoperative management. The change in carbohydrate metabolism can best be described as a state of reduced tolerance to administered glucose (Ross et al. 1966) which denotes a reduction in the rate at which glucose disappears from the extracellular fluid. This may arise from a suppression of ability of the pancreas to respond to a glucose load (Wright et al. 1974) or from a reduction in the biological activity in the insulin secreted.
Our finding of a two-to three-fold increase in both peaks of insulin secretion during a glucose infusion test in the immediate postoperative period implies facilitation of the response rather than inhibition, thus amplifying the conclusion of Ross et al. (1966) and Lindseth (1972) that no deficiency exists. Glucose intolerance may therefore be related to a reduction in insulin activity by other hormones or by a change in the nature of the secreted insulin. Evidence from this Unit and elsewhere has shown increases in the activity of glucocorticoids, growth hormone and catecholamines in the postoperative periods (Ross et al. 1966 , Lindseth 1972 , Giddings et al. 1974 ). The response of glucagon still awaits clarification. Each of these hormones can induce, either in part or wholly, the change seen after operation but there is as yet no general agreement on the part played by any one of them. No information is available on the composition of the insulin secreted in the postoperative period and this is currently under investigation.
The studies after intravenous feeding demonstrate the interaction between the metabolic response to injury and therapy. If only fluid and electrolytes are given, the exaggerated pancreatic response returns to normal within four days.
This indicates the relatively minor nature of the metabolic disturbance created nowadays by elective surgery of moderate severity. Administration of a carbohydrate intake providing 2400 kcal/day, equivalent to 600 g glucose, would appear at first sight to prolong or potentiate the response. Even sorbitol, which was at one time Section ofSurgery 833 considered to act independently of insulin, has a significant effect, although less marked than glucose. However, other features of the metabolic response to injurynitrogen excretion, and urinary sodium and potassium excretion -had returned to normal by this time. It is therefore concluded that the effects seen on the fourth postoperative day are those of therapy, being the pancreatic response to an intake of carbohydrate in excess of the normal load rather than to any augmentation of the response to injury. A solitary hyperfunctioning adenoma is the most common lesion and is manifest from the autonomy of its secretion. Surgical removal produces excellent results. In diffuse adenomatosis and hyperplasia, however, the whole pancreas is involved in the excessive secretion. Diffuse adenomatosis is easily recognized by the naked 'Present address: Royal Infirmary, Bristol eye as multiple fleshy tumours but examination of histological sections frequently shows areas of hyperplasia even in parts which are macroscopically normal. Generalized microscopic hyperplasia may also exist without macroscopic adenoma formation. In this second group of conditions it seems that the whole pancreas is overactive, perhaps in response to a trophic hormone yet to be identified. A total or subtotal resection of the pancreas is therefore indicated. Islet cell carcinoma may present in a number of ways depending on whether the tumour size and situation or its excessive secretion are the first to become symptomatic. Treatment may need to be directed against mitotic activity or hormonal activity or both. The histological diagnosis of endocrine malignancy is frequently difficult and evidence of invasion may easily be overlooked.
In a minority of cases the insulinoma is only one component of a multiple endocrine adenopathy (MEA). In type 1 MEA (Wermer's syndrome) islet cell adenoma or carcinoma, pituitary adenoma, and parathyroid adenoma of hyperplasia coexist. The term apudoma has been proposed to describe these lesions (Szijj et al. 1969) , since the constituent tumours may have a common cell origin in the neutral crest and all have the capacity for amine precursor uptake and decarboxylation, that is polypeptide synthesis. The secretion of such tumours may include gastrin, glucagon, adrenocorticotrophic hormone and serotonin in addition to insulin.
Two years after the first description of functioning islet cell carcinoma (Wilder et al. 1927 ) the first curative operation was carried out (Howland et al. 1929) . In 1944 A 0 Whipple set out his famous diagnostic triad: blood glucose less than 40 mg/100 ml, symptoms provoked by fasting, and relieved by glucose. Since then the diagnosis has been made more frequently, due to increased awareness, improved laboratory techniques for the measurement of plasma glucose and the introduction of radioimmunoassay for insulin.
The prevalence of the condition is not known with certainty but is probably less than 1 :100 000 of the population (Moldow & Connelly 1968). Women predominate and the maximum incidence is in the fourth to sixth decades, but cases have been reported in all age groups.
The clinical diagnosis is not usually difficult if it is thought of. Minor episodes of hypoglycaemia are common in clinical practice and so it might be thought that an attack due to insulinoma would be easily recognized. Sometimes a dramatic episode of tremor, pallor, sweating,
